Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.02 CAD | -1.66% | +6.87% | +7.73% |
Jun. 05 | Green Thumb Reportedly Explores Merger with Boston Beer | CI |
Jun. 05 | Boston Beer's Stock Decline Presents 'More Balanced Risk/Reward,' Morgan Stanley Says | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 53.67 times its estimated earnings per share for the ongoing year.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.73% | 2.82B | D+ | ||
-13.44% | 1.33B | - | ||
+53.28% | 508M | - | ||
-6.82% | 421M | - | ||
+69.01% | 205M | - | ||
-3.90% | 95.53M | - | - | |
-23.58% | 79.73M | - | ||
+25.00% | 57.52M | - | C | |
+23.60% | 51.62M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GTII Stock
- Ratings Green Thumb Industries Inc.